Intellia Therapeutics (NTLA) vs Trinity Biotech (TRIB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Intellia Therapeutics is the larger company by market cap ($1.64 billion vs $5.5 million), about 299.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | NTLA | TRIB |
|---|---|---|
| Share price | $11.71 | $6.75 |
| Market cap | $1.64B | $5.49M |
| 1-day change | -5.34% | -5.59% |
| YTD return | +30.26% | — |
| 1-year return | -42.71% | — |
| 5-year return | -91.03% | — |
| EPS (TTM) | $-3.35 | $-60.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.25 | $52.50 |
| 52-week low | $7.95 | $5.01 |
| Distance from 52-week high | -58.55% | -87.14% |
| Analyst consensus | buy | — |
| Avg. price target upside | +97.35% | — |
| Average volume | 4.16M | 21.63K |
| Shares outstanding | 140.13M | 813.13K |
| Employees | 377 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Intellia Therapeutics is about 299.0 times larger than Trinity Biotech by market value ($1.64B vs $5.49M).
About Intellia Therapeutics
NTLA stock →Intellia Therapeutics, Inc. operates as a clinical-stage genome editing company focused on developing potentially curative therapeutics using CRISPR/Cas9-based technologies.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 377 employees
NTLA vs TRIB FAQ
Which is bigger, Intellia Therapeutics or Trinity Biotech?
Intellia Therapeutics (NTLA) is larger, with a market capitalization of $1.64B compared with $5.49M for Trinity Biotech (TRIB).
Are Intellia Therapeutics and Trinity Biotech in the same industry?
Yes. Both are classified in the Biotechnology: In Vitro & In Vivo Diagnostic Substances industry within the Health Care sector.